Martine Rothblatt Sells 9,500 Shares of United Therapeutics (NASDAQ:UTHR) Stock

United Therapeutics Corporation (NASDAQ: UTHR - Get Free Report) CEO Martine Rothblatt sold 9,500 shares of the firm's stock in a transaction that occurred on Monday, April 13th. The shares were sold at an average price of $574.86, for a total value of $5,461,170.00. Following the transaction, the chief executive officer directly owned 40,513 shares of